Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06707129 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Collect confirmed cases of NAFLD patients and enroll them in the study. Select patients with NASH and fibrosis stage F2-4 confirmed by liver biopsy, and collect clinical and pathological data for relevant evaluation and definition. Establish a NASH "fibrosis reversal" pathological evaluation system, based on a new reversal standard, establish non-invasive alternative indicators, and observe indicators.
Trial Details
NCT Number NCT06707129
Lead Sponsor Beijing Municipal Administration of Hospitals
Conditions
(from sponsor)		 Non-alcoholic Fatty Liver Disease
Related terms Non-alcoholic Fatty Liver Disease
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov